On December 20, 2024, the Food and Drug Administration conferred accelerated approval for encorafenib (Braftovi, Array BioPharma Inc., a subsidiary of Pfizer Inc.) in conjunction with cetuximab and mF...
Liver TransplantLiver transplantation is a life-saving intervention in patients with end-stage liver disease or acute liver failure. Adequate nutrition is an important component of pre-transplant prep...
Immunotherapy Immunotherapy has transformed the way bladder cancer is treated, opening up new opportunities for patients, especially those with advanced or resistant disease. Through the power ...
Liver transplantationLiver transplant is a life-saving intervention for patients with end-stage liver disease, acute liver failure, and some genetic disorders. Though the physical and medical aspects ...
IntroductionLiver transplant surgery has seen tremendous progress in the last few decades, transforming the therapeutic possibilities of patients with end-stage liver disease, acute liver failure, and...
IntroductionLiver transplantation is a life-saving intervention for end-stage liver disease patients, including alcohol-related cirrhosis (ALC) patients. Alcohol-related cirrhosis is the result of chr...
IntroductionLiver transplant is a life-saving operation for end-stage liver disease, acute liver failure, or some metabolic disorders. But demand for liver transplantation far outweighs the supply o...
Liver transplantLiver transplantation is a life-threatening surgery for those afflicted by end-stage liver disease, acute liver failure, or certain metabolic conditions. As serious as the operation ...
On December 18, 2024, the Food and Drug Administration sanctioned ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or ...
On December 4, 2024, the Food and Drug Administration sanctioned durvalumab (Imfinzi, AstraZeneca) for adults with limited-stage small cell lung cancer (LS-SCLC) whose condition remains stable after...